retatrutide vs semaglutide vs tirzepatide Retatrutide vs. Semaglutide vs. Tirzepatide:

10.1002/adma.201601101 46 KellumJ

Directly suppresses appetite at the cerebral level

B.JungM

[29, 30, 31] Risk factors: Diabetes (especially in combination with SGLT2 inhibitors use) Reduced oral intake and severe GI symptoms Dehydration Presentation: Nausea, vomiting, abdominal pain Anion gap metabolic acidosis Elevated ketones Normal or mildly elevated glucose Key point: EDKA has not been observed in non-diabetic patients in large cohort data

In thyroid cancer, various selenium supplements have shown variable anticancer activity

Sterne JAC, Hernn MA, Reeves BC et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions